Ocean Biomedical Inc.

10/29/2024 | Press release | Distributed by Public on 10/29/2024 14:46

Management Change/Compensation Form 8 K

Item 5.02 Appointment of an Officer.

On October 23, 2024, Elizabeth Ng notified the Company's Board of Directors that she would be taking a sabbatical for personal reasons. Director, M. Michelle Berrey was appointed to act as Interim Chief Executive Officer, effective immediately. There have been no compensation arrangements made, and when determined by the Company's Compensation Committee, such arrangements shall be disclosed pursuant to a Current Report on Form 8-K.